Trupanion (TRUP) Projected to Post Quarterly Earnings on Wednesday

Trupanion (NASDAQ:TRUP - Get Free Report) is anticipated to issue its quarterly earnings data after the market closes on Wednesday, February 19th. Analysts expect the company to announce earnings of $0.06 per share and revenue of $335.45 million for the quarter. Parties interested in listening to the company's conference call can do so using this link.

Trupanion Trading Up 1.2 %

Shares of Trupanion stock traded up $0.60 on Friday, reaching $49.63. 417,004 shares of the company's stock were exchanged, compared to its average volume of 432,739. The company has a market capitalization of $2.10 billion, a P/E ratio of -155.09, a price-to-earnings-growth ratio of 8.03 and a beta of 1.60. Trupanion has a 52 week low of $19.69 and a 52 week high of $57.90. The firm's 50-day moving average is $48.78 and its two-hundred day moving average is $47.77. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.66 and a current ratio of 1.66.

Insider Buying and Selling

In other Trupanion news, EVP Steve Weinrauch sold 11,916 shares of the firm's stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $53.00, for a total transaction of $631,548.00. Following the transaction, the executive vice president now directly owns 48,978 shares in the company, valued at approximately $2,595,834. This trade represents a 19.57 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Fawwad Qureshi sold 622 shares of the firm's stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $52.61, for a total value of $32,723.42. Following the transaction, the chief financial officer now owns 9,867 shares in the company, valued at approximately $519,102.87. This trade represents a 5.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 26,597 shares of company stock worth $1,416,742 in the last ninety days. Corporate insiders own 5.50% of the company's stock.

Analyst Ratings Changes

TRUP has been the topic of a number of research analyst reports. Stifel Nicolaus increased their price target on Trupanion from $42.00 to $44.00 and gave the stock a "hold" rating in a report on Monday, January 6th. Northland Securities increased their price target on Trupanion from $45.00 to $50.00 and gave the stock a "market perform" rating in a report on Thursday, October 31st. Finally, Piper Sandler upgraded Trupanion from a "neutral" rating to an "overweight" rating and set a $57.00 price target on the stock in a report on Thursday, January 23rd. Two research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Trupanion currently has an average rating of "Moderate Buy" and a consensus target price of $45.33.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.